Thousands of lives across the country will be changed forever as a new sickle cell drug, Voxeletor, has been approved for use in the NHS following a recommendation from the National Institute for Health and Care Excellence (NICE). Voxeletor will be administered as a daily tablet. In England, an estimated 17,000 people are living with...
Subscribe to Inside Success magazine for full access to stay in the know and make a real difference. Your subscription helps us empower disadvantaged youth by helping them find jobs, achieve financial stability, and overcome social barriers.
